Please login to the form below

sepsis

This page shows the latest sepsis news and features for those working in and with pharma, biotech and healthcare.

TiGenix has another adipose-derived product, Cx611, which is currently undergoing a phase I/II trial in severe sepsis.

Takeda offers €520m for stem cell firm TiGenix

as well as additional indications such as sepsis.
CHMP backs Europe’s first allogeneic stem cell therapy

Along with Cx601, TiGenix has another adipose stem cell product (Cx611) in phase II trials for severe sepsis and a cardiac stem cell preparation (AlloCSC-01) heading for phase III in
UK Sepsis Trust named Communiqué charity of the year

Wins praise from the judges for its HCP engagement. The UK Sepsis Trust picked up the Charity, Patient or Professional Association of the Year at last week’s Comm uniqué Awards. ... Since the charity’s formation, mortality rates in the UK have
UK Sepsis Trust teams up with sepsis feature film Starfish

In its unique capacity to communicate with audiences, a popular portrayal of the damage sepsis can do presents an unprecedented opportunity to move and educate in equal measure. ... According to the charity, sepsis affects 150, 000 people in the UK
Dept of Health kicks off nationwide sepsis awareness campaign

The survey 1, 687 people also found 25% of those questioned were unaware that sepsis constitutes a medical emergency. ... The campaign will distribute resources on sepsis, including leaflets, posters and safety netting tools, in public healthcare

More from news
Approximately 4 fully matching, plus 29 partially matching documents found.

Leicester NHS Trust’s staff intranet is integral to HCPs’ working day

Clinical education is another well-used section of the intranet; while anything on infection prevention is widely viewed, for example, information on C. difficile, MRSA and sepsis.
30 Women Leaders in UK Healthcare (part 3)

One notable project involved Williams reformulating the active ingredient from a GSK mouthwash, chlorhexidine, into a gel to help prevent neonatal sepsis – thereby turning a similar consumer health product into a
Pharma deals in May 2015

The option is exercisable on completion of the phase II studies in acute kidney injury related to sepsis.
The impending threat of antibiotic resistance

Causes of death by infection in the pre-antibiotic era . Childbirth. 9 women in 1000 die in childbirth - 40% from sepsis. ... Every year 35, 000 people die from sepsis in the UK – some of these deaths are from antibiotic resistant infections.
Detecting and managing NS

Campaign:Increasing awareness of neutropenic sepsis (NS). Timescale:2009 to 2010. The publication of two reports from the National Chemotherapy Advisory Group (NCAG) and the National Confidential Enquiry into Patient Outcome ... the early recognition and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

TiGenix appoints Dr Marie Paule Richard

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is